In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Spectrum closes another private placement

Executive Summary

After netting $19mm from three investors last month, Spectrum Pharmaceuticals (urology and oncology) has now netted $9.5mm, this time through a registered direct offering to two existing investors. The company sold 1.7mm common shares at $5.83 (an 11% premium) and also issued 90-day warrants to buy 857k shares at the same price. Rodman & Renshaw was the placement agent.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Investment in Public Equity
    • Private Placement

Related Companies